REGULATION OF TIGHT JUNCTION PROTEINS AND BLADDER EPITHELIAL PARACELLULAR PERMEABILITY BY AN ANTIPROLIFERATIVE FACTOR FROM PATIENTS WITH INTERSTITIAL CYSTITIS
Authors:
- 1 December 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 174 (6) , 2382-2387
Abstract
Previous reports have suggested that the bladder epithelial barrier may be compromised in interstitial cystitis (IC). Antiproliferative factor (APF) is a small glycoprotein made specifically by bladder epithelial cells in patients with IC that induces changes in expression of certain epithelial cell proteins and profoundly inhibits cell growth. Therefore, we confirmed the increased permeability and decreased tight junction formation of bladder epithelial cell monolayers grown from biopsies in patients with IC compared to cells from normal controls. We then determined the effect of APF on the permeability of normal bladder epithelial cell monolayers and the expression of tight junction proteins. Permeability was determined by measuring the C-mannitol and H-inulin flux between cells in confluent monolayers on Transwell culture plates (Corning, Corning, New York). Tight junction formation was assessed by immunofluorescence microscopy and the expression of specific proteins was determined by Western blot. APF treatment caused significant increases in the paracellular permeability of normal bladder epithelial cell monolayers and the attenuation of tight junctions compared to mock APF, similar to changes seen in IC cells. APF treatment also decreased expression of the tight junction proteins zonula occludens-1 and occludin. Because of its apparent effects on bladder epithelial cell tight junctions and paracellular permeability in vitro, APF may contribute to the leakiness of the bladder epithelial barrier seen in IC.Keywords
This publication has 23 references indexed in Scilit:
- Distribution of the tight junction proteins ZO-1, occludin, and claudin-4, -8, and -12 in bladder epitheliumAmerican Journal of Physiology-Renal Physiology, 2004
- Human ENS regulates the intestinal epithelial barrier permeability and a tight junction-associated protein ZO-1 via VIPergic pathwaysAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2003
- Role of membrane proteins in permeability barrier function: uroplakin ablation elevates urothelial permeabilityAmerican Journal of Physiology-Renal Physiology, 2002
- Bladder permeability barrier: recovery from selective injury of surface epithelial cellsAmerican Journal of Physiology-Renal Physiology, 2002
- ANTIGENIC AND ULTRASTRUCTURAL MARKERS ASSOCIATED WITH UROTHELIAL CYTODIFFERENTIATION IN PRIMARY EXPLANT OUTGROWTHS OF MOUSE BLADDERCell Biology International, 2002
- Loss of Epithelial Integrity Resulting from E-Cadherin Dysfunction Predisposes Airway Epithelial Cells to Adenoviral InfectionAmerican Journal of Respiratory Cell and Molecular Biology, 2000
- Transport of IGF-I across epithelial cell monolayersJournal of Endocrinology, 1999
- THE ROLE OF URINARY POTASSIUM IN THE PATHOGENESIS AND DIAGNOSIS OF INTERSTITIAL CYSTITISJournal of Urology, 1998
- The rat mucosal mast cell chymase, RMCP-11, alters epithelial cell monolayer permeability in association with altered distribution of the tight junction proteins ZO-1 and occludinEuropean Journal of Cell Biology, 1998
- Epithelial Dysfunction in Nonbacterial Cystitis (Interstitial Cystitis)Journal of Urology, 1991